I just want to highlight a meeting in November, New approaches to the treatment of Parkinson’s, Wednesday, 12th November, 2025, Burlington House, Piccadilly, London, W1J 0BA.

In the dynamic field of drug discovery, the search for new treatments for Parkinson’s disease has never been more critical. It is estimated 10 million people worldwide are living with Parkinson’s – a chronic, progressive neurodegenerative condition resulting from the loss of the dopamine-containing cells of the substantia nigra. Motor and non-motor symptoms of the condition are wide ranging and current treatments only help to manage a small subset of the symptoms and do not modify the disease progression. But there is a wealth of research to find new and better therapeutics for Parkinson’s.

There is a fantastic lineup of speakers, with presentations on the underlying biology and potential targets and 5 drug discovery programmes (and 1 more to come) highlighting some of the different approaches being undertaken. These presentations also underline the challenge of delivering therapeutic agents into the brain and highlight key learnings that would be invaluable to anyone involved in CNS drug discovery. Whilst the oral programme has been completed there is still the opportunity for poster presentation, poster abstract submissions should be emailed to events@hg3.co.uk Deadline for submissions – Midnight (BST) 5th September, 2025.

Image created with ChatGTP

The RSC-BMCS are offering a small number of bursaries to attend the meeting in person. Applications are open to PhD and post-doctoral applicants studying at academic institutions or non-profit institutions.

Full details are on the conference website https://www.rscbmcs.org/events/parkinsons25/ , and registration is now open. https://registrations.hg3conferences.co.uk/hg3/323/register.